hotspot -WSS

hotspot

author：focus 2025-10-02 11:09:26 - browse：241

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： An inside look at PIPEs, biotech's buzzy new financing tool

Wikipedia

explore

WSS

RaDonda Vaught to speak at CommonSpirit event on patient safety

FDA approves Recor Medical high blood pressure device

How to address the problem of discarded donor organs

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Will General Catalyst be the first of many hospital takeovers?

leisure time

hotspot

focus

Moonlake's readout produced a cash windfall. Risks remain

Pfizer highlights cancer drugs it thinks could reignite investor interest

Continuity nursing helped my family in our darkest PICU moments

RSV vaccines may be linked to small increased risk of developing GBS

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

UCSF medical school apologizes for unethical prisoner experiments

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Biotech companies concerned about China biosecurity crackdown

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biotech incubator Curie.Bio graduates its first startup

explore

FogPharma raises $145 million in rare Series E round

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

In search for therapies for solid tumors, companies turn to claudin

UCSF medical school apologizes for unethical prisoner experiments

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

hotspot

Wikipedia

explore

explore